Literature DB >> 8250618

Effect of hormone replacement therapy on markers of bone metabolism in RA.

W F Lems, H R van den Brink, M I Gerrits, H J van Rijn, J W Bijlsma.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8250618      PMCID： PMC1005200          DOI： 10.1136/ard.52.11.835-b

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

1.  Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation.

Authors:  J Risteli; I Elomaa; S Niemi; A Novamo; L Risteli
Journal:  Clin Chem       Date:  1993-04       Impact factor: 8.327

2.  The effect of the menopause and hormone replacement therapy on serum carboxyterminal propeptide of type I collagen.

Authors:  C Hassager; G Fabbri-Mabelli; C Christiansen
Journal:  Osteoporos Int       Date:  1993-01       Impact factor: 4.507

3.  The pathophysiology of peri- and postmenopausal bone loss.

Authors:  L Nilas; C Christiansen
Journal:  Br J Obstet Gynaecol       Date:  1989-05

4.  Adjuvant oestrogen treatment increases bone mineral density in postmenopausal women with rheumatoid arthritis.

Authors:  H R van den Brink; W F Lems; A A van Everdingen; J W Bijlsma
Journal:  Ann Rheum Dis       Date:  1993-04       Impact factor: 19.103

5.  Serum osteocalcin and carboxyterminal propeptide of type I procollagen in rheumatoid arthritis.

Authors:  H Kröger; J Risteli; L Risteli; I Penttilä; E Alhava
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

6.  Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen.

Authors:  J Melkko; S Niemi; L Risteli; J Risteli
Journal:  Clin Chem       Date:  1990-07       Impact factor: 8.327

7.  Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma.

Authors:  I Elomaa; P Virkkunen; L Risteli; J Risteli
Journal:  Br J Cancer       Date:  1992-08       Impact factor: 7.640
  7 in total
  1 in total

1.  Hormone replacement therapy, calcium and vitamin D3 versus calcium and vitamin D3 alone decreases markers of cartilage and bone metabolism in rheumatoid arthritis: a randomized controlled trial [ISRCTN46523456].

Authors:  Helena Forsblad d'Elia; Stephan Christgau; Lars-Ake Mattsson; Tore Saxne; Claes Ohlsson; Elisabeth Nordborg; Hans Carlsten
Journal:  Arthritis Res Ther       Date:  2004-08-06       Impact factor: 5.156
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.